Stocks / Pharmaceuticals

VERAPharmaceuticals

Vera Therapeutics, Inc.
$34.301d +7.2%5d -1.6%settled close · 2026-09-17
Mkt cap $2.8B (3/25)β 0.9452w $30–44Shares 71.4M (A)Ind. Pharmaceutical PreparationsNasdaq since 2021Emp. 249HQ Brisbane, CAveratx.com
Who’s talkingIdea Scout · free

Who’s talking about VERA

No tracked investor commentary on VERA yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 3 Nov 2026

Confirmed date · consensus EPS -1.57. Reactions below are the next settled session over the prior close.
ReportWhenEPS actual vs est.Reaction
10 Aug 2026after the close-1.52 vs -1.61-3.8%
The options tape

Notable options days

Sessions in the last 120 where VERA’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 14 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-15
2026-08-26
2026-08-25
2026-08-24
2026-08-17
2026-08-14
2026-08-04
2026-07-07
2026-07-06
2026-07-02
2026-06-29
2026-06-26
2026-06-25
2026-06-22
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on VERA is in this morning’s Brief. Get The Brief — $20/mo →